Analysis of Opko Health manpower and management performance can provide insight into Opko Health stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Opko Health future performance. Additionally take a look at Your Equity Center.
Opko Health Management EffectivenessThe company has return on total asset (ROA) of (5.64) % which means that it has lost $5.64 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (15.4) % meaning that it generated substantial loss on money invested by shareholders.
Opko Health Workforce Comparison
Opko Health is considered to be number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers - Specialty & Generic industry is now estimated at about 23,295. Opko Health totals roughly 6,030 in number of employees claiming about 26% of equities under Drug Manufacturers - Specialty & Generic industry.
Opko Health Profit MarginsThe company has Profit Margin (PM) of (28.96) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (22.78) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.23.
Opko Health Stakeholders
|Philip Frost Chairman of the Board, CEO|
|Phillip Frost Chairman of the Board, CEO|
|Jane Hsiao Vice Chairman of the Board, Chief Technical Officer|
|Steven Rubin Executive Vice President - Administration, Director|
|Akhtar Ashfaq Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division|
|Adam Logal CFO, Chief Accounting Officer, Sr. VP and Treasurer|
|Robert Fishel Independent Director|
|Robert Baron Independent Director|
|Alice Yu Independent Director|
|Richard Lerner Independent Director|
|Dmitry Kolosov Independent Director|
|Richard Pfenniger Independent Director|
|Thomas Beier Director|
|John Paganelli Independent Director|
|Richard Krasno Independent Director|
|Anne Fields IR Contact Officer|
|Thomas Nusbickel Chief Commercial Officer of the Company's Renal Division|
|Miriam Miller IR Contact Officer|
Opko Health employes about 6030 people. The company is managed by 18 executives with total tenure of roughly 123 years, averanging almost 6.0 years of service per executive having 335.0 employee per reported executive.
|Revenue Per Employee||170.8 K|
|Revenue Per Executive||57.2 M|
|Net Loss Per Employee||49.5 K|
|Net Loss Per Executive||16.6 M|